INTEGRATED FILING — Other than Banks



General information about company

Scrip code 524037
NSE Symbol RAMAPHO
MSEI Symbol NOTLISTED
ISIN INE809A01032
Name of Company RAMA PHOSPHATES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-May-2025   16:15:00
End date and time of board meeting 14-May-2025   17:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-14
Indicate Company website link for updated RPT policy of the Company www.ramaphosphates.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 2009215000 7436908000
Other income 21192000 35413000
Total Income 2030407000 7472321000
2 Expenses
(a) Cost of materials consumed 1362447000 4854501000
(b) Purchases of stock-in-trade 64085000 118575000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -154818000 233016000
(d) Employee benefit expense 100900000 350098000
(e) Finance costs 39261000 132058000
(f) Depreciation and amortisation expense 20494000 82023000
(g) Other Expenses
1 Other Expenses 462974000 1446470000
Total other expenses 462974000 1446470000
Total expenses 1895343000 7216741000
3 Profit before exceptional and extraordinary items and tax 135064000 255580000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 135064000 255580000
6 Extraordinary items 0 0
7 Profit before tax 135064000 255580000
8 Tax Expense
Current tax 50186000 54189000
Deferred tax 32385000 64641000
Total tax expenses 82571000 118830000
9 Net Profit Loss for the period from continuing operations 52493000 136750000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 52493000 136750000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 52493000 136750000
17 Details of equity share capital
Paid-up equity share capital 176743000 176743000
Face value of equity share capital 5 5
18 Reserves excluding revaluation reserve 2717475000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.48 3.86
Diluted earnings (loss) per share from continuing and discontinued operations 1.48 3.86
20 Debt equity ratio 0.0033 0.0033
21 Debt service coverage ratio 0.0204 0.0204
22 Interest service coverage ratio 0.0356 0.0356
23 Disclosure of notes on financial results Textual Information(1)


Text Block
Textual Information(1) 1.The above audited results for the quarter ended March 31, 2025 and the audited results for the year ended March 31, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on May 14, 2025. The Statutory Auditors have audited these financial results for the quarter and year ended March 31, 2025 and have issued an unmodified report on these results. 2.The above results are prepared in compliance with Indian Accounting Standard (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013 and notified by the Ministry of Corporate Affairs under the Companies (Indian Accounting Standards) Rules, 2015 & amendments issued thereafter and other accounting principles generally accepted in India. 3.Figures for the quarter ended 31st March, 2025 and 31st March, 2024 are the balancing figures between audited figures in respect of the full financial year ended on those dates and the published reviewed year-to-date figures up to the third quarter of the respective financial year. 4.A) The Company is focused on two business segments: Fertilizers, Micro Nutrients & Chemicals and Soya/Agri. Based on the management approach as defined in Ind AS 108 - 'Operating Segments', the Cheif Operating Decision Maker evaluates the Company's performance and allocates resources based on an analysis of various performance indicators by business segments. Accordingly, information has been presented along these business segments. The accounting principles used in the preparation of the financial results are consistently applied to record revenue and expenditure in individual segment. B) Segment results represents the profit/(loss) before interest and Tax charged by each segment without allocation of central administrative costs, finance cost and other income. 5. The Board of Directors at its meeting held on November 13, 2024 approved, sub-division/ split of the existing 1 (One) Equity Share of the Company, having face value of Rs. 10/- (Rupees Ten Only) each, into 2 (Two) Equity Share having face value of Rs. 5/- (Rupees Five Only) each and the same was approved by the Shareholders through Postal Ballot on, January 1, 2025. On and from the Record date February 7, 2025, the sub-division/ split became effective on both the stock exchanges (BSE & NSE). Hence, as prescribed under IND AS, the Company has presented basic and diluted earnings per share basis the new number of share for the current as well as previous periods. 6.The Company has received Environmental Clearance (EC) from Ministry of Environment, Forest and Climate Change (MOEF) for its new Greenfield project at Dhule to manufacture of 216000 MT PA SSP Fertilizer and 90000 MT PA Sulphuric Acid. Accordingly Company is executing its schedule Phase -1 project to manufacture SSP Fertilizer and trial production is expected to commence by 4th quarter of FY 2026. 7.The Company does not have any subsidiary company or associate company or Joint Venture company, as on 31st March 2025 and consequently the Company is not required to prepare consolidated financial results as per applicable laws and regulations. 8.The results of the Company are also available on stock exchange websites www.nseindia.com, www.bseindia.com and on the Company website at (www.ramaphosphates.com) 9. The Board of Directors haverecommended dividend of Rs. 0.25 per Equity share (5% on face value of Rs. 5/- each.) 10. During the financial year, the Company has opted for settlement of long-pending income tax disputes pertaining to the Assessment Years 2010-11 & 2011–12 under the Government of India’s Vivad se Vishwas Scheme. In accordance with the terms of the scheme, the Company has paid a total amount of Rs. 494.12 Lacs towards full and final settlement of the said disputes. The payment has been duly accounted for under earlier tax expenses in the Statement of Profit and Loss for the year. As a result, the related contingent liabilities disclosed in earlier periods, to the extent of the settled amount, stand extinguished. 11. The Company has long term credit rating ICRA A- by ICRA. 12. Figures of the previous quarter/period /Year have been regrouped/rearranged, where ever necessary to make them comparable.


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 255580000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 132058000
Adjustments for depreciation and amortisation expense 82023000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains -11997000
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow -10387000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -3823000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 187874000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 62680000
Adjustments for decrease (increase) in trade receivables 148588000
Adjustments for decrease (increase) in other current assets -323561000
Adjustments for increase (decrease) in trade payables 75256000
Adjustments for increase (decrease) in other current liabilities 40433000
Adjustments for provisions 2759000
Total adjustments for working capital 6155000
Total adjustments for reconcile profit (loss) 194029000
Net cash flows from (used in) operations 449609000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 51698000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 397911000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 397911000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 8000
Purchase of property plant and equipment 74606000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 9560000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -10094000
Proceeds from government grants 34936000
Net cash flows from (used in) investing activities before extraordinary items -40196000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -40196000
Cash flows from used in financing activities
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 210203000
Dividends paid 0
Interest paid 128062000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -20592000
Net cash flows from (used in) financing activities before extraordinary items -358857000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities -358857000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -1142000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -1142000
Cash and cash equivalents cash flow statement at beginning of period 2835000
Cash and cash equivalents cash flow statement at end of period 1693000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 176743000
Reserves and surplus 3535416000
Money received against share warrants 0
Total shareholders' funds 3712159000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 0
Deferred tax liabilities (net) 117919000
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 17340000
Long-term provisions 12793000
Total non-current liabilities 148052000
6 Current liabilities
Short-term borrowings 1223995000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 38361000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 979948000
Total Trade payable 1018309000
Other current liabilities 218595000
Short-term provisions 20873000
Total current liabilities 2481772000
Total equity and liabilities 6341983000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 1642274000
Producing properties 0
Intangible assets 1046000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 254900000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 1898220000
ii Non-current investments 3224000
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 77997000
Total non-current assets 1979441000
Current assets
Current investments 0
Inventories 2089769000
Trade receivables 602707000
Cash and cash equivalents 1693000
Bank balance other than cash and cash equivalents 113615000
Short-term loans and advances 2526000
Other current assets 1552232000
Total current assets 4362542000
Total assets 6341983000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Fertilizers, Micro Nutrients & Chimicals 1750153000 6624005000
2 Soya/Agri 259062000 812903000
Total Segment Revenue 2009215000 7436908000
Less: Inter segment revenue 0 0
Revenue from operations 2009215000 7436908000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Fertilizers, Micro Nutrients & Chimicals 205933000 490143000
2 Soya/Agri -4995000 -13653000
Total Profit before tax 200938000 476490000
i. Finance cost 39261000 132058000
ii. Other Unallocable Expenditure net off Unallocable income 26613000 88852000
Profit before tax 135064000 255580000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Fertilizers, Micro Nutrients & Chimicals 5879611000 5879611000
2 Soya/Agri 327961000 327961000
Total Segment Asset 6207572000 6207572000
Un-allocable Assets 134411000 134411000
Net Segment Asset 6341983000 6341983000
4 Segment Liabilities
Segment Liabilities
1 Fertilizers, Micro Nutrients & Chimicals 2208424000 2208424000
2 Soya/Agri 267348000 267348000
Total Segment Liabilities 2475772000 2475772000
Un-allocable Liabilities 154052000 154052000
Net Segment Liabilities 2629824000 2629824000
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/S. Khandelwal and Mehta LLP Yes 31-May-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth


Signatories details

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date


Signatory Details
Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rama Phosphates Limited Rama Petrochemicals Limited Entities with joint control or significant influence over entity Purchase of goods or services 603200000 Approved by Audit Committee 901000 0 0
2 Rama Phosphates Limited Rama Capital and Fiscal Services Private Limited Entities with joint control or significant influence over entity Purchase of goods or services 603200000 Approved by Audit Committee 1000 0 0
3 Rama Phosphates Limited Rainbow Agri Industries Limited Entities with joint control or significant influence over entity Any other transaction Receiving of Services (Rent Paid) Approved by Audit Committee 5400000 0 0
4 Rama Phosphates Limited Rama Industries Limited Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 3254000 2304000 0
5 Rama Phosphates Limited Rama Industries Limited Entities with joint control or significant influence over entity Loan Approved by Audit Committee 0 74000000 0 Loan 0.09 180 days Unsecured Working Capital Requirement
6 Rama Phosphates Limited Rama Industries Limited Entities with joint control or significant influence over entity Any other transaction Loan Repayment Approved by Audit Committee 74000000 0 0
7 Rama Phosphates Limited Jupiter Corporate Services Private Limited Entities with joint control or significant influence over entity Any other transaction ICD Taken Approved by Audit Committee 28000000 0 0
8 Rama Phosphates Limited Jupiter Corporate Services Private Limited Entities with joint control or significant influence over entity Any other transaction ICD Repaid Approved by Audit Committee 28000000 0 0
9 Rama Phosphates Limited Jupiter Corporate Services Private Limited Entities with joint control or significant influence over entity Any other transaction Interest Paid on ICD Approved by Audit Committee 2496000 0 0
10 Rama Phosphates Limited Haresh Ramsinghani Key management personnel of entity Remuneration Approved by Audit Committee 11717000 0 0
11 Rama Phosphates Limited Jambu Kumar Parakh Key management personnel of entity Remuneration Approved by Audit Committee 9425000 0 0
12 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Remuneration Approved by Audit Committee 587000 0 0
13 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Any other transaction Loan Given Approved by Audit Committee 0 700000 600000
14 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Any other transaction Loan Repayment Approved by Audit Committee 100000 0 0
15 Rama Phosphates Limited Brij Lal Khanna Director Any other transaction Sitting Fees Paid Approved by Audit Committee 105000 0 0
16 Rama Phosphates Limited Kishore P Sukhthankar Director Any other transaction Sitting Fees Paid Approved by Audit Committee 30000 0 0
17 Rama Phosphates Limited Pushpangadan Mangari Director Any other transaction Sitting Fees Paid Approved by Audit Committee 60000 0 0
18 Rama Phosphates Limited Ratneshwar Prasad Director Any other transaction Sitting Fees Paid Approved by Audit Committee 90000 0 0
19 Rama Phosphates Limited Nilanjana.H. Ramsinghani Director Any other transaction Sitting Fees Paid Approved by Audit Committee 15000 0 0
Total value of transaction during the reporting period 164181000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0